Allos SA
BOVESPA:ALOS3
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
18.16
26.66
|
Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ALOS3 stock under the Base Case scenario is 22 BRL. Compared to the current market price of 18.85 BRL, Allos SA is Undervalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Allos SA
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
Valuation History
Historical valuation for ALOS3 cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Allos SA
Balance Sheet Decomposition
Allos SA
Current Assets | 6.8B |
Cash & Short-Term Investments | 5.8B |
Receivables | 544.7m |
Other Current Assets | 379.2m |
Non-Current Assets | 22.9B |
Long-Term Investments | 21.5B |
PP&E | 89.9m |
Intangibles | 823.9m |
Other Non-Current Assets | 490.5m |
Current Liabilities | 3B |
Accounts Payable | 75.6m |
Accrued Liabilities | 52.8m |
Other Current Liabilities | 2.9B |
Non-Current Liabilities | 12.6B |
Long-Term Debt | 6.7B |
Other Non-Current Liabilities | 5.9B |
Earnings Waterfall
Allos SA
Revenue
|
2.7B
BRL
|
Cost of Revenue
|
-734m
BRL
|
Gross Profit
|
2B
BRL
|
Operating Expenses
|
-776.5m
BRL
|
Operating Income
|
1.2B
BRL
|
Other Expenses
|
-455.2m
BRL
|
Net Income
|
765.3m
BRL
|
Free Cash Flow Analysis
Allos SA
BRL | |
Free Cash Flow | BRL |
ALOS3 Profitability Score
Profitability Due Diligence
Allos SA's profitability score is 68/100. The higher the profitability score, the more profitable the company is.
Score
Allos SA's profitability score is 68/100. The higher the profitability score, the more profitable the company is.
ALOS3 Solvency Score
Solvency Due Diligence
Allos SA's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Allos SA's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALOS3 Price Targets Summary
Allos SA
According to Wall Street analysts, the average 1-year price target for ALOS3 is 29.96 BRL with a low forecast of 23.23 BRL and a high forecast of 35.7 BRL.
Dividends
Current shareholder yield for ALOS3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ALOS3 stock under the Base Case scenario is 22 BRL.
Compared to the current market price of 18.85 BRL, Allos SA is Undervalued by 14%.